Search for: "Ely Lilly"
Results 841 - 860
of 2,157
Sort by Relevance
|
Sort by Date
18 Feb 2014, 3:18 pm
Products in this category are: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Testosterone is a 19-carbon steroid hormone. [read post]
18 Feb 2014, 7:09 am
Eli Lilly Authors Guild Inc., et al. v. [read post]
2 Feb 2014, 9:33 pm
Eli Lilly and... [read post]
30 Jan 2014, 10:36 am
Indianapolis, Indiana - Indiana patent attorneys for Eli Lilly and Company of Indianapolis, Indiana ("Lilly") filed a lawsuit in the Southern District of Indiana alleging that Glenmark Generics, Inc., USA of Mahwah, New Jersey ("Glenmark") infringed Antifolate Combination Therapies, Patent No. 7,772,209, which has been issued by the U.S. [read post]
28 Jan 2014, 3:18 am
Medtronic was party to a license agreement with Mirowski, as Medtronic was successor in interest to the original licensee (Eli Lilly). [read post]
28 Jan 2014, 2:24 am
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
27 Jan 2014, 9:47 am
Indianapolis, Indiana - An Indiana patent attorney sued in the Southern District of Indiana on behalf of Eli Lilly and Company of Indianapolis, Indiana; Daiichi Sankyo Co., Ltd. of Tokyo, Japan ("Daiichi Sankyo"); Daiichi Sankyo, Inc. of Parsippany, New Jersey ("DSI"); and Ube Industries, Ltd. of Yamaguchi, Japan alleging that Par Pharmaceutical Companies, Inc. [read post]
7 Jan 2014, 5:19 pm
Tradjenta (linagliptin) is manufactured by Eli Lilly and Boehringer Ingelheim and approved for sale in 2011. [read post]
7 Jan 2014, 2:15 pm
'With the U.S. patent expiration of Cymbalta last December and that of Evista coming in March, we expect 2014 to be the most financially challenging year of Lilly's current period of patent expirations,' said Derica Rice, Lilly executive vice president, global services and chief financial officer. [read post]
7 Jan 2014, 2:15 pm
'With the U.S. patent expiration of Cymbalta last December and that of Evista coming in March, we expect 2014 to be the most financially challenging year of Lilly's current period of patent expirations,' said Derica Rice, Lilly executive vice president, global services and chief financial officer. [read post]
7 Jan 2014, 7:46 am
See, e.g, In re Eli Lilly & Co., No. 3:09MC296 (AWT), 2010 WL 2509133, at *4 (D. [read post]
2 Jan 2014, 2:08 am
in "Bilateral Investment Treaties: Claiming Compensation from Foreign Governments under Bilateral Investment Treaties for failing to provide adequate IP Protection" 27 July 2013 I mentioned a possible claim by the US company Eli Lilly & Co. against the Canadian government under Chapter II of the agreement between the US, Canadian and Mexican governments establishing the North America Free Trade [read post]
27 Dec 2013, 8:44 am
Eli Lilly & Co., No. 0:13-591-CMC, 2013 U.S. [read post]
27 Dec 2013, 1:27 am
* Despite its apparent logic, Eli Lilly's application was logically incoherent. [read post]
18 Dec 2013, 2:32 am
An FDA spokesman told The Times that so far, the agency has received commitments to follow the plan from two major drug producers, former Pfizer subsidiary Zoetis and Elanco, which is owned by Eli Lilly & Co. [read post]
16 Dec 2013, 1:23 pm
Similarly in Actavis v Eli Lilly [2013] EWCA Civ 517, the Court of Appeal confirmed that the English courts have jurisdiction to hear claims for declarations of non-infringement in relation to foreign designations of European patents where there is no challenge to validity. [read post]
12 Dec 2013, 7:12 am
In short, where the patent holder has already obtained an SPC on the basis of a patent protecting an innovative active ingredient and a marketing authorisation for a medicinal product containing that ingredient as the single active ingredient, and that SPC entitles him to oppose the use of that active ingredient, either alone or in combination with other active ingredients, Article 3(c) of the SPC Regulation must be interpreted as precluding that patent holder from obtaining –- on the basis of… [read post]
9 Dec 2013, 7:06 am
Eli Lilly and Co., 2013 WL 6345442, No. 2:12–cv–9366 (C.D. [read post]
4 Dec 2013, 7:06 am
Eli Lilly & Co., 998 F.2d 931, 938 (Fed. [read post]
3 Dec 2013, 3:10 am
Eli Lilly, of course, believes the cost of the test should be covered without restriction. [read post]
